Z Squared ZSQR
NASDAQ ZSQR
$4.16 +0.01 (+0.24%)
At close: Sep 30, 2026 · 4:00 PM EDT

Z Squared (ZSQR) EBT Margin (2025 - 2026)

Updated

Z Squared's EBT Margin was -871.16% in Q2 2026, up 2663.04 percentage points from the prior quarter.

Analysis

Z Squared (ZSQR) EBT Margin (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Z Squared's EBT Margin was -798.69% through Jun 30, 2026, up 12341.27 percentage points year-over-year; for FY2025, it came in at -900.72%.

  • EBT Margin shows a four-year change of +17031.66 percentage points (FY2021 to FY2025).
  • In earlier years, EBT Margin was -17932.37% in FY2021.
  • Quarterly EBT Margin has moved between -5440.95% (Q1 2025) and -188.26% (Q4 2025) over five years.
  • Per Business Quant data, ZSQR's EBT Margin in the three quarters before Q2 2026 was -3534.20% (Q1 2026), -188.26% (Q4 2025) and -1220.84% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 26.66%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 25.18%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -4.11%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 29.63%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 18.19%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 27.53%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -131.41%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 41.75%
10 Z Squared 220.48 Mn 193.72 Mn -1.77 Mn -871.16%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -871.16%
Mar 31, 2026 -3,534.20%
Dec 31, 2025 -188.26%
Sep 30, 2025 -1,220.84%
Mar 31, 2025 -5,440.95%
API Access

Z Squared EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=ZSQR&period=max&api_key=YOUR_API_KEY